反応式
FC(F)C1N(C)C=C(O)C(=O)C=1.F[CH:14](F)[C:15]1[N:20](C)[C:19]([CH:22]([OH:27])[C:23]([F:26])([F:25])[F:24])=[C:18]([OH:28])[C:17](=[O:29])[CH:16]=1.C(O)C(N)(CO)CO.C(N(CC(O)=O)CC(O)=O)CN(CC(O)=O)CC(O)=O>CC#N>[OH:28][C:18]1[C:17](=[O:29])[CH:16]=[C:15]([CH3:14])[NH:20][C:19]=1[CH:22]([OH:27])[C:23]([F:26])([F:24])[F:25]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
Proceeding in a similar manner as A, 2-difluoromethyl-5-hydroxy-1-methyl-1H-pyridin-4-one was converted to 6-difluoromethyl-3-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one. 1H NMR (DMSO-d6+1 drop of D2O) δ ppm: 7.12 (t, J=52.8 Hz, 1H), 6.56 (s, 1H), 5.83 (b, 1H), 3.79 (s, 3H). 19F NMR (DMSO-d6+1 drop of D2O) δ ppm: −73.3 (3F), −117.8 (2F). MS (m/z) 274.1 [M+1]+. HPLC conditions: Column: XTerra MS C18 5 μm 4.6×250 mm. Mobile phase: A=the aqueous phase: 4 mM Tris, 2 mM EDTA, pH 7.4; B=the organic phase: CH3CN. The gradient program: B %: 0 min. 5%, 15 min. 55%, 25 min. 55%, 25.05 min. 5%, 30 min. 5%. Flow rate=1 ml/min.; injection volume=5 μL; wavelength: 220, 254, 280, 450 nm. Retention time of 2-Difluoromethyl-5-hydroxy-1-methyl-1H-pyridin-4-one=6.7 min. Retention time of 6-difluoromethyl-3-hydroxy-1-methyl-2-(2,2,2-trifluoro-1-hydroxy-ethyl)-1H-pyridin-4-one=11.4 min.
後処理
- custom0 min
- custom5%, 15 min
- custom55%, 25 min
- custom55%, 25.05 min
- custom5%, 30 min
出典と根拠
- ORDレコード
- ord-c7c8e3f7953848709c5424ac9ec89800
- 出典データセット
- uspto-grants-2011_09
- 特許番号
- US08026261B2
関連ノート
読み込み中…